1. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 2008;135:1907-1913.PMID:
18854185.
2. Esrailian E, Spiegel BM, Targownik LE, Dubinsky MC, Targan SR, Gralnek IM. Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes. Aliment Pharmacol Ther 2007;26:1005-1018.PMID:
17877507.
3. Spiegel BM, Ho W, Esrailian E, et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol 2009;7:168-174.e1.PMID:
18952199.
4. Kappelman MD, Bousvaros A, Hyams J, et al. Intercenter variation in initial management of children with Crohn's disease. Inflamm Bowel Dis 2007;13:890-895.PMID:
17286275.
5. Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 2008;57:549-558.PMID:
18178610.
6. Farraye FA, Melmed GY, Lichtenstein GR, Kane SV. ACG clinical guideline: preventive care in inflammatory bowel disease. Am J Gastroenterol 2017;112:241-258.PMID:
28071656.
7. Mehta F. Report: economic implications of inflammatory bowel disease and its management. Am J Manag Care 2016;22(3 Suppl): s51-s60.PMID:
27269903.
8. Ahmed S, Siegel CA, Melmed GY. Implementing quality measures for inflammatory bowel disease. Curr Gastroenterol Rep 2015;17:14PMID:
25762473.
9. Melmed GY, Siegel CA, Spiegel BM, et al. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis 2013;19:662-668.PMID:
23388547.
10. MacLean CH, Louie R, Leake B, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000;284:984-992.PMID:
10944644.
11. Shekelle PG, MacLean CH, Morton SC, Wenger NS. Acove quality indicators. Ann Intern Med 2001;135(8 Pt 2): 653-667.PMID:
11601948.
12. Campbell SM, Braspenning J, Hutchinson A, Marshall MN. Research methods used in developing and applying quality indicators in primary care. BMJ 2003;326:816-819.PMID:
12689983.
13. Donabedian A. The role of outcomes in quality assessment and assurance. QRB Qual Rev Bull 1992;18:356-360.PMID:
1465293.
14. Calvet X, Panés J, Alfaro N, et al. Delphi consensus statement: quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units. J Crohns Colitis 2014;8:240-251.PMID:
24295646.
17. Siegel CA, Allen JI, Melmed GY. Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013;11:908-912.PMID:
23747710.
18. Song HK, Lee KM, Jung SA, et al. Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2nd Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul. Intest Res 2016;14:240-247.PMID:
27433146.
19. Nguyen GC, Boland K, Afif W, et al. Modified Delphi process for the development of choosing wisely for inflammatory bowel disease. Inflamm Bowel Dis 2017;23:858-865.PMID:
28509817.
20. Crandall W, Kappelman MD, Colletti RB, et al. ImproveCareNow: the development of a pediatric inflammatory bowel disease improvement network. Inflamm Bowel Dis 2011;17:450-457.PMID:
20602466.
21. Crandall WV, Margolis PA, Kappelman MD, et al. Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics 2012;129:e1030-e1041.PMID:
22412030.
23. Tinsley A, Ehrlich OG, Hwang C, et al. Knowledge, attitudes, and beliefs regarding the role of nutrition in IBD among patients and providers. Inflamm Bowel Dis 2016;22:2474-2481.PMID:
27598738.
24. Hou JK, Gasche C, Drazin NZ, et al. Assessment of gaps in care and the development of a care pathway for anemia in patients with inflammatory bowel diseases. Inflamm Bowel Dis 2017;23:35-43.PMID:
27749376.